Composition for prevention of nausea or vomiting
Provided is a composition for preventing nausea or vomiting, including a 5-HT 3 receptor antagonist and a corticosteroid, and having a pH adjusted to 3.0-6.0. Provided also is a method for preparing a composition for preventing nausea or vomiting, including: mixing a 5-HT 3 receptor antagonist with a corticosteroid; and adjusting pH of the mixture obtained from the preceding operation to 3.0-6.0.
1. A method for preparing a composition, comprising:
mixing a 5-HT 3 receptor antagonist with a corticosteroid; and
adjusting pH of the mixture obtained from said mixing to 3.0or higher but less than 6.0,
wherein the 5-HT 3 receptor antagonist comprises at least one selected from ondansetron, ramosetron, derivatives thereof and pharmaceutically acceptable salts thereof,
wherein the corticosteroid comprises at least one selected from dexamethasone, derivatives thereof and pharmaceutically acceptable salts thereof,
wherein the concentration of the 5-HT 3 receptor antagonist is 0.0-10 mg/ml, and
wherein the concentration of the corticosteroid is 1-4 mg/ml.
2. The method according to claim 1 , wherein said adjusting pH is carried out by using a pH modifier or a buffering agent.
3. The method according to claim 2 , wherein the pH modifier comprises at least one selected from the group consisting of organic acids, hydrochloric acid, phosphoric acid, carbonic acid and cyanic acid; and the buffering agent comprises at least one selected from the group consisting of organic acid buffers, phosphate buffers and carbonate buffers.
4. The method according to claim 1 , wherein the composition is a liquid composition.
5. A composition comprising a 5-HT 3 receptor antagonist and a corticosteroid, and having a pH adjusted to 3.0 or higher but less than 6.0,
wherein the 5-HT 3 receptor antagonist comprises at least one selected from ondansetron, ramosetron, derivatives thereof and pharmaceutically acceptable salts thereof,
wherein the corticosteroid comprises at least one selected from dexamethasone, derivatives thereof and pharmaceutically acceptable salts thereof,
wherein the concentration of the 5-HT 3 receptor antagonist is 0.01-10 mg/ml, and
wherein the concentration of the corticosteroid is 1-4 mg/ml.
6. The composition according to claim 5 , wherein the composition further comprises a pH modifier or a buffering agent.
7. The composition according to claim 6 , wherein the pH modifier comprises at least one selected from the group consisting of organic acids, hydrochloric acid, phosphoric acid, carbonic acid and cyanic acid.
8. The composition according to claim 6 , wherein the buffering agent comprises at least one selected from the group consisting of organic acid buffers, phosphate buffers and carbonate buffers.
9. The composition according to claim 5 , wherein the composition is a liquid composition.